Monte Rosa Therapeutics, Inc. (GLUE)
18.81
-0.07
(-0.37%)
USD |
NASDAQ |
May 22, 16:00
18.80
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Profit Margin (Quarterly) : -1.06K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -- |
| Myriad Genetics, Inc. | -17.02% |
| BioRestorative Therapies, Inc. | -9.29K% |
| Kyntra Bio, Inc. | -404.8% |
| Kura Oncology, Inc. | -401.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.10% |
| Return on Assets | -27.11% |
| Return on Invested Capital | -37.24% |
| Gross Profit Margin (Quarterly) | 51.81% |
| Operating Margin (Quarterly) | -1.19K% |
| Return on Net Operating Assets | -237.7% |